Skip to content

Frontlight ResearchEarly access

Trial site

Local Institution - 010-801

Nashville, Tennessee 37203, United StatesNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Colorectal cancer

Running trials

Active, not recruiting
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
NCT04793958· Phase 3· Mirati Therapeutics Inc.· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Local Institution - 010-801: trial site – Frontlight Research